GL1X · GenesisL1 explorer

MolNFT v1 · #189718 · protein

Structure of human SGLT2-MAP17 complex bound with empagliflozin

7VSI: “Structure of human SGLT2-MAP17 complex bound with empagliflozin”. Electron microscopy, 2 ligands (PLM, 7R3). MolNFT v1 #189718 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
7VSI
Type
protein
Length
616 residues
Chains
2
Method
electron microscopy
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
P31639, Q13113
Ligands
PLM, 7R3

Structure

electron microscopy · 2 distinct chains.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein586—P31639
B—protein30—Q13113

Ligands and binding sites

  • PLM · Palmitic acid · ligand · 2 copies · chains A
  • 7R3 · (2S,3R,4R,5S,6R)-2-[4-chloranyl-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3, 4,5-triol · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 7VSI · Structure of human SGLT2-MAP17 complex bound with empagliflozin · the same entry in another collection · chain A against A, TM-score 1.00
  • P31639 · AlphaFold monomer V2.0 prediction for SODIUM/GLUCOSE cotransporter 2 (P31639) · a predicted model of the same protein · chain A against A, TM-score 0.98
  • Q13113 · AlphaFold monomer V2.0 prediction for PDZK1-interacting protein 1 (Q13113) · a predicted model of the same protein · chain B against A, TM-score 0.86

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.